Avalo Therapeutics
AVTX
AVTX
65 hedge funds and large institutions have $56.2M invested in Avalo Therapeutics in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 25 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
56% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 25
59% less capital invested
Capital invested by funds: $136M → $56.2M (-$79.9M)
Holders
65
Holding in Top 10
–
Calls
$6K
Puts
$12K
Top Buyers
| 1 | +$1.87M | |
| 2 | +$237K | |
| 3 | +$52.6K | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$31.4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$25K |
Top Sellers
| 1 | -$2.57M | |
| 2 | -$1.31M | |
| 3 | -$670K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$386K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$208K |